For 1QCY2017, Sanofi India posted results which were below expectations on all fronts. The sales came in at `513cr v/s. `550cr expected, registering a yoy de-growth of 1.1%. On the operating front, the EBITDA margin came in at 12.0% (17.6% expected) v/s. 17.7% in 1QCY2016. Despite better GPM (Gross Profit Margin), which came in at 54.2% v/s 53.2% in 1QCY2016, the EBIDTA margin was lower, as the other expenses rose by 26.8% yoy, while employee expenses rose by 6.9% yoy. Consequently, the Adj. PAT came in at `60cr v/s. `83cr in 1QCY2016, a yoy de-growth of 27.4%. This was against the expectations of `71cr. We maintain our Neutral rating.
Download Full Report View Full Report in BrowserPlease Wait...
Please Wait...
Please Wait...
Please Wait...
Please Wait...
Please Wait...
Please Wait...
Please Wait...
Please Wait...
Please Wait...
Please Wait...
Please Wait...